One World Products Inc Quick Ratio (PNTT) starting from the third quarter 2022 to third quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
One World Products Inc   (PNTT)

One World Products Inc 's Quick Ratio

PNTT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 0.55 below One World Products Inc average.

Within Major Pharmaceutical Preparations industry 534 other companies have achieved higher Quick Ratio than One World Products Inc in third quarter 2022. While Quick Ratio total ranking in the third quarter 2022 has deteriorated compared to the prior quarter from 2416 to 3118.

Explain Quick Ratio?
How much Cash & cash equivalents PNTT´s has?
What are PNTT´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PNTT Quick Ratio (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4		 (Sep 30 2021)
Q3
Y / Y Current Liabilities Change 93.76 % -4.78 % 15.69 % -10.5 % 36.43 %
Y / Y Cash & cash equivalent Change -21.04 % -15.56 % 73.29 % 1362.95 % 1995.61 %
Quick Ratio MRQ 0.55 1.04 0.89 0.9 1.36
PNTT's Total Ranking # 3118 # 2416 # 2520 # 2083 #
Seq. Current Liabilities Change 78.81 % -16.72 % 20.62 % 7.87 % -12.13 %
Seq. Cash & cash equivalent Change -4.3 % -2.83 % 18.71 % -28.47 % 2.34 %



Quick Ratio third quarter 2022 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 535
Healthcare Sector # 1007
Overall Market # 3118


Quick Ratio Statistics
High Average Low
1.38 0.58 0.06
(Sep 30 2019)   (Dec 31 2020)




Financial Statements
One World Products Inc 's Current Liabilities $ 3 Millions Visit PNTT's Balance sheet
One World Products Inc 's Cash & cash equivalent $ 2 Millions Visit PNTT's Balance sheet
Source of PNTT's Sales Visit PNTT's Sales by Geography


Cumulative One World Products Inc 's Quick Ratio

PNTT's Quick Ratio for the trailling 12 Months

PNTT Quick Ratio

 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months
Y / Y Current Liabilities TTM Growth 20.88 % 6.25 % 6.22 % 3.87 % 18.32 %
Y / Y Cash & cash equivalent TTM Growth 26.36 % 116.76 % 423.3 % 1259.58 % 580.53 %
Quick Ratio TTM 0.8 1.03 1.07 1 0.77
Total Ranking TTM # 2153 # 2267 # 2145 # 2409 # 2184
Seq. Current Liabilities TTM Growth 21.01 % -1.21 % 4.06 % -2.83 % 6.36 %
Seq. Cash & cash equivalent TTM Growth -6.21 % -4.29 % 11.29 % 26.49 % 60.9 %

Quick ratio ranking by company, industry and sector >> Back to PNTT Financial Strength Comparisons >> Go to Compare PNTT Quick Ratio to its Competitors

On the trailing twelve months basis Due to jump in Current Liabilities in the Q3 2022 to $2.74 millions, cumulative Quick Ratio decreased to 0.8 above the PNTT average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 573 other companies have achieved higher Quick Ratio than One World Products Inc . While Quick Ratio overall ranking has improved so far to 2569, from total ranking during the twelve months ending second quarter 2022 at 4596.

Explain Quick Ratio?
How much Cash & cash equivalents PNTT´s has?
What are PNTT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 574
Healthcare Sector # 1152
Within the Market # 3118


trailing twelve months Quick Ratio Statistics
High Average Low
1.07 0.51 0.07
(Mar 31 2022)   (Sep 30 2016)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Myovant Sciences Ltd   1.48 $ 371.290  Millions$ 251.691  Millions
Paratek Pharmaceuticals Inc   1.46 $ 57.009  Millions$ 38.976  Millions
Seelos Therapeutics inc   1.46 $ 30.511  Millions$ 20.887  Millions
Abeona Therapeutics Inc   1.44 $ 18.167  Millions$ 12.600  Millions
Universe Pharmaceuticals Inc  1.44 $ 18.860  Millions$ 13.098  Millions
Rockwell Medical inc   1.43 $ 27.564  Millions$ 19.338  Millions
Petros Pharmaceuticals inc   1.41 $ 11.182  Millions$ 7.945  Millions
Avadel Pharmaceuticals Plc  1.39 $ 60.935  Millions$ 43.765  Millions
Morphosys Ag  1.38 $ 450.633  Millions$ 326.645  Millions
Inflarx N V  1.36 $ 19.821  Millions$ 14.589  Millions
Biora Therapeutics Inc   1.35 $ 37.060  Millions$ 27.391  Millions
Lunai Bioworks Inc   1.34 $ 7.972  Millions$ 5.930  Millions
Palatin Technologies Inc   1.34 $ 21.192  Millions$ 15.861  Millions
Effector Therapeutics Inc   1.32 $ 32.956  Millions$ 24.968  Millions
Urogen Pharma Ltd   1.32 $ 28.686  Millions$ 21.799  Millions
Kala Bio inc   1.30 $ 52.393  Millions$ 40.241  Millions
Puma Biotechnology Inc   1.30 $ 77.960  Millions$ 59.987  Millions
Heron Therapeutics Inc   1.30 $ 121.746  Millions$ 93.876  Millions
Evolus Inc   1.28 $ 65.572  Millions$ 51.271  Millions
Promis Neurosciences inc   1.28 $ 3.951  Millions$ 3.099  Millions
Unicycive Therapeutics Inc  1.27 $ 7.010  Millions$ 5.522  Millions
Royalty Pharma Plc  1.24 $ 1,400.975  Millions$ 1,131.625  Millions
Alkermes Plc   1.24 $ 580.182  Millions$ 469.555  Millions
9 Meters Biopharma Inc   1.23 $ 15.861  Millions$ 12.863  Millions
Evotec Se  1.23 $ 525.926  Millions$ 428.630  Millions
Organogenesis Holdings Inc   1.20 $ 107.250  Millions$ 89.273  Millions
Celyad Oncology Sa  1.19 $ 13.938  Millions$ 11.677  Millions
Aravive Inc   1.18 $ 27.896  Millions$ 23.730  Millions
Alaunos Therapeutics Inc   1.15 $ 37.807  Millions$ 32.869  Millions
Talphera Inc   1.11 $ 15.926  Millions$ 14.290  Millions

Date modified: 2026-09-08T15:10:47+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.